Results 211 to 220 of about 282,052 (348)
Ganglioside Binding Assay: A Complementary Approach for Enhanced Tetanus Toxoid Quality Control. [PDF]
Tanoue Y +10 more
europepmc +1 more source
Toxicity tests in animals: alternative models.
openaire +1 more source
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel +9 more
wiley +1 more source
Navigating complexity in modern toxicology: the role of omics in short-term in vivo studies. [PDF]
Mitchell CA +5 more
europepmc +1 more source
Thrombolytic proteins profiling: High‐throughput activity, selectivity, and resistance assays
We present optimized biochemical protocols for evaluating thrombolytic proteins, enabling rapid and robust screening of enzymatic activity, inhibition resistance, and fibrin affinity, stimulation, and selectivity. The outcome translates to key clinical indicators such as biological half‐life and bleeding risk. These assays streamline the development of
Martin Toul +3 more
wiley +1 more source
Revision of the Choices Nutrient Profiling System. [PDF]
Smorenburg H +9 more
europepmc +1 more source
China is Taking Steps toward Alternatives to Animal Testing [PDF]
Rodger Curren, Brian Jones
openalex +1 more source
Overview of molecular signatures of senescence and associated resources: pros and cons
Cells can enter a stress response state termed cellular senescence that is involved in various diseases and aging. Detecting these cells is challenging due to the lack of universal biomarkers. This review presents the current state of senescence identification, from biomarkers to molecular signatures, compares tools and approaches, and highlights ...
Orestis A. Ntintas +6 more
wiley +1 more source
Perspective of using <i>in vitro</i> models to understand immunotherapy-induced cytokine release syndrome. [PDF]
Perkins E +9 more
europepmc +1 more source

